ANAB
ANAPTYSBIO, INC · Healthcare · Market cap $1.4B
Insiders sold $249K net in the last 90 days ·1 seller, 0 buyers· 1 of 1 sale under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.8M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 2, 2026
RENTON HOLLINGS
ANAPTYSBIO, INC (ANAB) has 28 SEC Form 4 filings (70 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 8 insiders at ANAPTYSBIO, INC reported no open-market purchases and 25 open-market sales totaling $9.8M. The most active filer is CHIEF LEGAL OFFICER LOUMEAU ERIC J with 8 filings. Insiders have net sold $249K over the trailing 6 months. The most recent open-market filing is a sale of 5,000 shares by Director RENTON HOLLINGS, dated Oct 1, 2026, worth $249K.
- Industry:Biotechnology
- CEO:Daniel Faga
- Employees:104
- HQ:San Diego, CA, US
- IPO:2017-01-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
RENTON HOLLINGSFirst filing | Director | Sale | 5,000 | $249K | Oct 2 | -1.2% | SEC ↗ |
Schmid John P.First filing | Director | Sale | 30,968 | $1.2M | Apr 1 | +90.1% | SEC ↗ |
| President, CEO | Sale | 26,519 | $1.1M | Mar 27 | +87.9% | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 15,000 | $540K | Feb 13 | — | SEC ↗ | |
Marquet MagdaFirst filing | Director | Sale | 16,500 | $531K | Jan 16 | — | SEC ↗ |
| Chief Medical Officer | Sale | 5,475 | $163K | Jan 9 | — | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 3,315 | $99K | Jan 9 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 3,773 | $112K | Jan 9 | — | SEC ↗ | |
| President, CEO | Sale | 21,422 | $639K | Jan 9 | — | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 14,460 | $439K | Jan 8 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 2,862 | $86K | Jan 8 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 3,353 | $101K | Jan 8 | — | SEC ↗ | |
| President, CEO | Sale | 13,803 | $415K | Jan 8 | — | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 4,475 | $129K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 6,329 | $183K | Jan 6 | — | SEC ↗ | |
Faga DanielFirst filing | President, CEO | Sale | 22,964 | $662K | Jan 6 | — | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 5,045 | $145K | Jan 6 | — | SEC ↗ | |
| CHIEF LEGAL OFFICER | Sale | 15,000 | $510K | Dec 23 | — | SEC ↗ | |
Lizzul Paul F.First filing | Chief Medical Officer | Sale | 2,250 | $75K | Dec 23 | — | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 15,000 | $500K | Dec 23 | — | SEC ↗ | |
Ware J. AnthonyFirst filing | Director | Sale | 5,850 | $193K | Dec 23 | — | SEC ↗ |
LOUMEAU ERIC JFirst filing | CHIEF LEGAL OFFICER | Sale | 18,751 | $561K | Dec 18 | — | SEC ↗ |
LOUMEAU ERIC JFirst filing | CHIEF LEGAL OFFICER | Sale | 15,000 | $460K | Dec 18 | — | SEC ↗ |
LOUMEAU ERIC JFirst filing | CHIEF LEGAL OFFICER | Sale | 212 | $7K | Dec 18 | — | SEC ↗ |
MULROY DENNISFirst filing | CHIEF FINANCIAL OFFICER | Sale | 23,588 | $705K | Dec 18 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ANAB have?
ANAPTYSBIO, INC (ANAB) has 28 SEC Form 4 filings (70 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for ANAB?
The most recent Form 4 filing for ANAB on Tracefour is dated Oct 2, 2026.
Who is the most active insider at ANAB?
The most active SEC Form 4 filer at ANAB in the rolling window is CHIEF LEGAL OFFICER LOUMEAU ERIC J, with 8 filings.
What is the net insider flow at ANAB over the last 6 months?
Over the trailing 180 days, insiders at ANAB have net sold $249K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ANAB in the current window?
Inside the rolling window, insiders at ANAB bought $0 and sold $9.8M based on SEC Form 4 filings.
Can I get alerts for ANAB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ANAPTYSBIO, INC (ANAB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ANAPTYSBIO, INC is in the Healthcare sector.